SiSaf Ltd

SiSaf Ltd

Biotechnology Research

Guildford, England 1,392 followers

Delivering on the promise of RNA therapeutics

About us

We are an RNA delivery and therapeutics company. Our proprietary Bio-Courier® technology addresses the limitations of other RNA delivery technologies through the hybridization of organic materials with inorganic bioabsorbable silicon. Our Bio-Courier portfolio includes silicon stabilized hybrid lipid nanoparticles (sshLNP) that improve the stability, safety, and transfection efficiency of RNA. We use sshLNP to develop a pipeline of RNA therapeutics for rare genetic disorders and are maximizing the potential of our technology through research partnerships. Led by founder and leading biomaterials specialist Dr Suzanne Saffie-Siebert, SiSaf is a venture capital backed private company. Headquartered in Guildford, UK, we have fully integrated research labs and bio-analytical facilities, a scalable technology to fast-track development, and a growing patent estate with extensive freedom to operate.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Guildford, England
Type
Privately Held
Founded
2008
Specialties
drug delivery, drug development, Gene Therapy, Drug Reformulation, Corneal Dystrophy, Osteopetrosis, and Keloid scars

Locations

Employees at SiSaf Ltd

Updates

Similar pages

Browse jobs

Funding

SiSaf Ltd 12 total rounds

Last Round

Series B

US$ 13.2M

See more info on crunchbase